{"id":{"repo_id":"duquesne","oai_identifier":"oai:dsc.duq.edu:etd-3235"},"canonical_url":"https://search.ndltd.org/etd/duquesne/oai:dsc.duq.edu:etd-3235","repository":{"repo_id":"duquesne","name":"Duquesne","base_url":"https://dsc.duq.edu/do/oai/"},"display":{"title":"ISOLATION AND TOTAL SYNTHESIS OF SIGMA-2 LIGANDS FROM MARINE CYANOBACTERIA","abstract":"Cyanobacteria have been studied for over 50 years as a source of new antibiotics, antiviral, and anticancer drugs. The research described in this dissertation investigates marine cyanobacteria as a source of natural products with activity within the central nervous system and with cytotoxicity against breast cancer cells. Barbamide (1) is a known cyanobacterial metabolite that has been re-isolated from a variety of species and collection sites suggesting broad utility as a signaling molecule. Utilizing the psychoactive drug screening program, we screened barbamide for CNS activity and found that barbamide exhibited affinity for the kappa opioid receptor (KOR) and the sigma-2 receptor. Additionally, we isolated three veraguamide analogs from a cyanobacterial sample collected from Isla Mina in the Las Perlas Archipelago of Panama. Veraguamide C (2), veraguamide O (3), and veraguamide P (4) were determined to have affinity for the sigma-2 receptor as well as increased cytotoxicity for MDA-MB-231 TNBC cells compared to MCF-7 breast cancer cells. In order to further investigate the activity of the most potent cytotoxic agent (4), the total synthesis of 4 was proposed. After overcoming several synthetic challenges, the total synthesis was completed and was used for further biological evaluation and structure confirmation. Additionally, three analogs of 4 were synthesized in order to investigate some of the structure-activity relationships. These analogs were methoxy-veraguamide P (5), methoxy-veraguamide P amide (6) and veraguamide P amide (7). These compounds were screened for cytotoxicity and CNS activity. After isolation of multiple cyanobacterial natural products with CNS activity, an analysis was conducted on the bioactivity of our cyanobacterial fraction library to evaluate the effectiveness of our sample processing method in identifying active fractions. A new method for pre-fractionation was proposed to improve the detection of CNS active fractions. This research is an example of exploring the rich bioactivity found from marine cyanobacteria.","abstract_html":"Cyanobacteria have been studied for over 50 years as a source of new antibiotics, antiviral, and anticancer drugs. The research described in this dissertation investigates marine cyanobacteria as a source of natural products with activity within the central nervous system and with cytotoxicity against breast cancer cells. Barbamide (1) is a known cyanobacterial metabolite that has been re-isolated from a variety of species and collection sites suggesting broad utility as a signaling molecule. Utilizing the psychoactive drug screening program, we screened barbamide for CNS activity and found that barbamide exhibited affinity for the kappa opioid receptor (KOR) and the sigma-2 receptor. Additionally, we isolated three veraguamide analogs from a cyanobacterial sample collected from Isla Mina in the Las Perlas Archipelago of Panama. Veraguamide C (2), veraguamide O (3), and veraguamide P (4) were determined to have affinity for the sigma-2 receptor as well as increased cytotoxicity for MDA-MB-231 TNBC cells compared to MCF-7 breast cancer cells. In order to further investigate the activity of the most potent cytotoxic agent (4), the total synthesis of 4 was proposed. After overcoming several synthetic challenges, the total synthesis was completed and was used for further biological evaluation and structure confirmation. Additionally, three analogs of 4 were synthesized in order to investigate some of the structure-activity relationships. These analogs were methoxy-veraguamide P (5), methoxy-veraguamide P amide (6) and veraguamide P amide (7). These compounds were screened for cytotoxicity and CNS activity. After isolation of multiple cyanobacterial natural products with CNS activity, an analysis was conducted on the bioactivity of our cyanobacterial fraction library to evaluate the effectiveness of our sample processing method in identifying active fractions. A new method for pre-fractionation was proposed to improve the detection of CNS active fractions. This research is an example of exploring the rich bioactivity found from marine cyanobacteria.","abstract_has_math":false,"creators":["Hough, Andrea"],"institution":null,"degree_name":"PhD","degree_level":"Immediate Access","degree_discipline":"Medicinal Chemistry","degree_department":null,"school":null,"contributors":["Kevin Tidgewell","David Lapinsky","Marc Harrold","Jane Cavanaugh","Patrick Flaherty"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:51:57Z","subjects":["Cyanobacteria","Cancer","Sigma-2","Central nervous system","Breast cancer","Barbamide","Veraguamide","Marine cyanobacteria","Natural Products Chemistry and Pharmacognosy"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/2166","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dsc.duq.edu/etd/2166","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dsc.duq.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adsc.duq.edu%3Aetd-3235","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Kevin Tidgewell","David Lapinsky","Marc Harrold","Jane Cavanaugh","Patrick Flaherty"]},{"key":"dc:creator","label":"Author","values":["Hough, Andrea"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2023-08-12T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2023-08-05T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medicinal Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Immediate Access"]},{"key":"thesis:degree_name","label":"Degree Name","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Cyanobacteria","Cancer","Sigma-2","Central nervous system","Breast cancer","Barbamide","Veraguamide","Marine cyanobacteria","Natural Products Chemistry and Pharmacognosy"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/2166"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Cyanobacteria have been studied for over 50 years as a source of new antibiotics, antiviral, and anticancer drugs. The research described in this dissertation investigates marine cyanobacteria as a source of natural products with activity within the central nervous system and with cytotoxicity against breast cancer cells. Barbamide (1) is a known cyanobacterial metabolite that has been re-isolated from a variety of species and collection sites suggesting broad utility as a signaling molecule. Utilizing the psychoactive drug screening program, we screened barbamide for CNS activity and found that barbamide exhibited affinity for the kappa opioid receptor (KOR) and the sigma-2 receptor. Additionally, we isolated three veraguamide analogs from a cyanobacterial sample collected from Isla Mina in the Las Perlas Archipelago of Panama. Veraguamide C (2), veraguamide O (3), and veraguamide P (4) were determined to have affinity for the sigma-2 receptor as well as increased cytotoxicity for MDA-MB-231 TNBC cells compared to MCF-7 breast cancer cells. In order to further investigate the activity of the most potent cytotoxic agent (4), the total synthesis of 4 was proposed. After overcoming several synthetic challenges, the total synthesis was completed and was used for further biological evaluation and structure confirmation. Additionally, three analogs of 4 were synthesized in order to investigate some of the structure-activity relationships. These analogs were methoxy-veraguamide P (5), methoxy-veraguamide P amide (6) and veraguamide P amide (7). These compounds were screened for cytotoxicity and CNS activity. After isolation of multiple cyanobacterial natural products with CNS activity, an analysis was conducted on the bioactivity of our cyanobacterial fraction library to evaluate the effectiveness of our sample processing method in identifying active fractions. A new method for pre-fractionation was proposed to improve the detection of CNS active fractions. This research is an example of exploring the rich bioactivity found from marine cyanobacteria."]},{"key":"dc:title","label":"Title","values":["ISOLATION AND TOTAL SYNTHESIS OF SIGMA-2 LIGANDS FROM MARINE CYANOBACTERIA"]}]}],"canonical_facts":{"dc:contributor":["Kevin Tidgewell","David Lapinsky","Marc Harrold","Jane Cavanaugh","Patrick Flaherty"],"dc:creator":["Hough, Andrea"],"dc:date.available":["2023-08-12T07:00:00Z"],"dc:date.created":["2023-08-05T07:00:00Z"],"dc:description.abstract":["Cyanobacteria have been studied for over 50 years as a source of new antibiotics, antiviral, and anticancer drugs. The research described in this dissertation investigates marine cyanobacteria as a source of natural products with activity within the central nervous system and with cytotoxicity against breast cancer cells. Barbamide (1) is a known cyanobacterial metabolite that has been re-isolated from a variety of species and collection sites suggesting broad utility as a signaling molecule. Utilizing the psychoactive drug screening program, we screened barbamide for CNS activity and found that barbamide exhibited affinity for the kappa opioid receptor (KOR) and the sigma-2 receptor. Additionally, we isolated three veraguamide analogs from a cyanobacterial sample collected from Isla Mina in the Las Perlas Archipelago of Panama. Veraguamide C (2), veraguamide O (3), and veraguamide P (4) were determined to have affinity for the sigma-2 receptor as well as increased cytotoxicity for MDA-MB-231 TNBC cells compared to MCF-7 breast cancer cells. In order to further investigate the activity of the most potent cytotoxic agent (4), the total synthesis of 4 was proposed. After overcoming several synthetic challenges, the total synthesis was completed and was used for further biological evaluation and structure confirmation. Additionally, three analogs of 4 were synthesized in order to investigate some of the structure-activity relationships. These analogs were methoxy-veraguamide P (5), methoxy-veraguamide P amide (6) and veraguamide P amide (7). These compounds were screened for cytotoxicity and CNS activity. After isolation of multiple cyanobacterial natural products with CNS activity, an analysis was conducted on the bioactivity of our cyanobacterial fraction library to evaluate the effectiveness of our sample processing method in identifying active fractions. A new method for pre-fractionation was proposed to improve the detection of CNS active fractions. This research is an example of exploring the rich bioactivity found from marine cyanobacteria."],"dc:identifier":["https://dsc.duq.edu/etd/2166"],"dc:language":["English"],"dc:subject":["Cyanobacteria","Cancer","Sigma-2","Central nervous system","Breast cancer","Barbamide","Veraguamide","Marine cyanobacteria","Natural Products Chemistry and Pharmacognosy"],"dc:title":["ISOLATION AND TOTAL SYNTHESIS OF SIGMA-2 LIGANDS FROM MARINE CYANOBACTERIA"],"thesis:degree_discipline":["Medicinal Chemistry"],"thesis:degree_level":["Immediate Access"],"thesis:degree_name":["PhD"]},"updated_at":"2026-11-19T07:51:57Z"}